1 March 2017
| Serge Latis
Most patients with papillary thyroid carcinoma (PTC) have excellent disease-specific survival (DSS). Even with lymph node metastatic recurrence, the 10-year survival is 85%, and 15-year survival 73%. There is a growing trend of minimising morbidity in differentiated thyroid carcinoma (DTC)...